Definitive radiotherapy for early (T1-T2) Glottic Squamous cell carcinoma: A 20 year Cleveland clinic experience

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Khan, Mohammad K ^a   Koyfman, Shlomo A ^b   Hunter, Grant K ^b   Reddy, Chandana A ^b   Saxton, Jerrold P ^b  

^a EMORY UNIVERSITY   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Carcinoma; Glottic carcinoma; Larynx; Outcome; Radiotherapy; Squamous cell

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; CORDOTOMY; DYSPHAGIA; EARLY CANCER; ENTERIC FEEDING; FEMALE; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX EDEMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SPEECH DISORDER; SQUAMOUS CELL CARCINOMA; TRACHEOSTOMY; VOICE;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; CARCINOMA, SQUAMOUS CELL; DEGLUTITION DISORDERS; DYSPHONIA; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HUMANS; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SMOKING; SURVIVAL RATE; TREATMENT OUTCOME; TRISMUS;

EID: 84869108158     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-193     Document Type: Article

References (18)

1. Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma. Laryngoscope 2008, 118:1417-1421. 10.1097/MLG.0b013e3181781791, 18528306.
2. Groome PA, O'Sullivan B, Mackillop WJ, Jackson LD, Schulze K, Irish JC, Warde PR, Schneider KM, Mackenzie RG, Hodson DI, et al. Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules. Int J Radiat Oncol Biol Phys 2006, 64:1002-1012. 10.1016/j.ijrobp.2005.10.010, 16414205.
3. Frata P, Cellai E, Magrini SM, Bonetti B, Vitali E, Tonoli S, Buglione M, Paiar F, Barca R, Fondelli S, et al. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. Int J Radiat Oncol Biol Phys 2005, 63:1387-1394. 10.1016/j.ijrobp.2005.05.013, 16115737.
4. Cho EI, Sasaki CT, Haffty BG. Prognostic significance of pretreatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 2004, 58:1135-1140. 10.1016/j.ijrobp.2003.08.002, 15001255.
5. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience. Radiother Oncol 2003, 68:105-111. 10.1016/S0167-8140(03)00059-8, 12972304.
6. Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?. Int J Radiat Oncol Biol Phys 2003, 55:322-328. 10.1016/S0360-3016(02)03938-X, 12527044.
7. Warde P, O'Sullivan B, Bristow RG, Panzarella T, Keane TJ, Gullane PJ, Witterick IP, Payne D, Liu FF, McLean M, et al. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 1998, 41:347-353. 10.1016/S0360-3016(98)00062-5, 9607350.
8. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 1997, 39:115-126.
9. Burke LS, Greven KM, McGuirt WT, Case D, Hoen HM, Raben M. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys 1997, 38:1001-1006. 10.1016/S0360-3016(97)00150-8, 9276365.
10. Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. T1N0 to T2N0 Squamous Cell Carcinoma of the Glottic Larynx Treated with Definitive Radiotherapy. Int J Radiat Oncol Biol Phys 2010, 78(2):461-466. 10.1016/j.ijrobp.2009.08.066, 20153124.
11. Greene FL, . American Joint Committee on Cancer AJCC cancer staging atlas. Book AJCC cancer staging atlas (Editor ed.^eds.) 2006, ix-352. City: Springer, ix, 352 p, American Joint Committee on Cancer.
12. Reddy SP, Hong RL, Nagda S, Emami B. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. Int J Radiat Oncol Biol Phys 2007, 69:1389-1394. 10.1016/j.ijrobp.2007.05.077, 17869013.
13. Trotti AP, Emami T, Hammond B, Jones E, Morrison C, Sagar W, Ridge S, Fu J, Ang K, K K. A randomized trial of hyperfractionation versus standard fractionation in T2 squamous cell carcinoma of the vocal cord. Int J Radiat Oncol Biol Phys 2006, 66:S15.
14. Akimoto T, Nonaka T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K, Furuya N, Hayakawa K, Mitsuhashi N, Nakano T. Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys 2006, 64:995-1001. 10.1016/j.ijrobp.2005.10.003, 16406396.
15. Nonoshita T, Shioyama Y, Nakamura K, Nakashima T, Ohga S, Yoshitake T, Ohnishi K, Terashima K, Asai K, Honda H. Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma. J Radiat Res (Tokyo) 2010, 51:481-484.
16. Misono S, Merati AL. Are patient-reported voice outcomes better after surgery or after radiation for treatment of T1 glottic carcinoma?. Laryngoscope 2011, 121:461-462. 10.1002/lary.21432, 21344419.
17. Higgins KM. What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility?. Laryngoscope 2011, 121:116-134. 10.1002/lary.21226, 21120828.
18. Khan MK, Koyfman S, Hunter GH, Reddy S, Saxton JP. Outcome of Early Glottic (T1/T2) Treated with Radiotherapy at the Cleveland Clinic Foundation: A 20 Year Experience. Int J Radiat Oncol Biol Phys 2009, 75(3):S418-419.